Related Experiment Video
Updated: Jul 11, 2025
11:48
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
15.8K
RhoA suppresses pseudorabies virus replication in vitro
Xin-Man Li1,2,3, Shi-Ping Wang1,2,3, Jin-Yuan Wang1,2,3
1College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China.
Virology Journal
|November 16, 2023
Summary
The RhoA protein acts as a host restriction factor, inhibiting pseudorabies virus (PRV) replication. Modulating RhoA activity impacts PRV proliferation, offering insights into viral pathogenesis and drug development.
Area of Science:
- Virology
- Cell Biology
- Molecular Biology
Background:
- Porcine pseudorabies virus (PRV) causes significant economic losses in the swine industry.
- Viruses utilize host cell processes, including the cytoskeleton, for replication and immune evasion.
- RhoA is a key regulator of the cytoskeleton, potentially involved in viral infections.
Purpose of the Study:
- To investigate the role of RhoA in PRV replication.
- To determine how RhoA modulation affects PRV proliferation.
- To elucidate the relationship between actin cytoskeleton dynamics and PRV infection.
Main Methods:
- Chemical drug treatment to inhibit or activate RhoA.
- Gene knockdown and overexpression strategies for RhoA.
- Assessment of PRV replication under different RhoA conditions.
- Use of actin-specific inhibitors like cytochalasin D.
Main Results:
- Inhibition or knockdown of RhoA promoted PRV proliferation.
- Overexpression or activation of RhoA inhibited PRV infection.
- PRV infection disrupted actin stress fibers.
- Inhibition of actin polymerization reduced PRV replication.
Conclusions:
- RhoA functions as a host restriction factor against PRV replication.
- Actin cytoskeleton polymerization is essential for PRV replication.
- Findings deepen understanding of PRV pathogenesis and inform antiviral strategies.
Related Concept Videos
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
01:29Viruses with RNA Genomes
34
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
34
01:23RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K